Meaning
Vascular constriction induced by elevated peptide concentrations marks a systemic physiological response to chronic decision fatigue in founders. This endothelin 1 surge occurs when persistent high-stakes pressure forces a shift from normal autonomous regulation toward a state of sustained hypertension. Such vasoconstriction lowers overall blood flow efficiency to peripheral tissues while increasing the shear stress load on internal vessel walls.
Biological Mechanism
Prolonged activation of the endocrine system initiates the release of this potent peptide from endothelial cells lining the arterial tree. The endothelin 1 surge acts upon receptors to contract smooth muscle cells, effectively narrowing the vessel diameter for extended periods. Chronic exposure to this state necessitates higher cardiac output to maintain oxygen delivery to the brain during peak cognitive demand.
Capacity Cost
Founders experience a measurable drop in sustained attention and physical endurance as the cardiovascular system prioritizes pressure maintenance over recovery. An endothelin 1 surge diverts available metabolic resources away from secondary processes to support this heightened state of alert. Capacity depletion becomes the primary consequence of this transition because the body interprets the executive burden as a physical threat requiring immediate containment.
Systemic Boundary
Autonomic recovery begins only when the external requirement for high-frequency decision making falls below the threshold of continued peptide secretion. Stabilization of the endothelin 1 surge requires the removal of the specific stimuli that maintain the constriction signal. Permanent vascular remodelling occurs if the system remains in this heightened state long enough to alter the mechanical properties of the vessel walls themselves.
